前药
亲脂性
生物利用度
药品
化学
药物输送
组合化学
药理学
生物化学
有机化学
医学
作者
Yuexuan Cheng,Chunhong Zhong,Shujing Yan,Chunli Chen,Xiaoli Gao
标识
DOI:10.4155/fmc-2022-0309
摘要
Prodrug strategy is critical for innovative drug development. Structural modification is the most straightforward and effective method to develop prodrugs. Improving drug defects and optimizing the physical and chemical properties of a drug, such as lipophilicity and water solubility, changing the way of administration can be achieved through specific structural modification. Designing prodrugs by linking microenvironment-responsive groups to the prototype drugs is of great help in enhancing drug targeting. In the meantime, making connections between prodrugs and suitable drug delivery systems could realize drug loading increases, greater stability, bioavailability and drug release control. In this paper, lipidic, water-soluble, pH-responsive, redox-sensitive and enzyme-activatable prodrugs are reviewed on the basis of structural modification.
科研通智能强力驱动
Strongly Powered by AbleSci AI